Japan’s Daiichi Sankyo offloads Ranbaxy

India’s Sun Pharmaceutical Industries is to pay US$3.2bn to acquire its troubled rival Ranbaxy Laboratories, perhaps leaving many at Japan’s Daiichi Sankyo, Ranbaxy’s current owner, breathing a sigh of relief.…